OTUD3: A Potential Drug Target and Biomarker for Disulfide-Bond Enrichment and Disease

Target Name: OTUD3

NCBI ID: G23252

OTUD3

OTUD3: A Potential Drug Target and Biomarker for Disulfide-Bond Enrichment and Disease

Disulfide bond formation is a critical post-translational modification that plays a central role in various cellular processes, including cell signaling, tissue repair, and inflammation. Defects in disulfide bond formation have been implicated in numerous diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The discovery of new drug targets and biomarkers for disulfide bond formation has the potential to lead to new treatments and therapies. In this article, we will focus on OTUD3, a protein that has been identified as a potential drug target and biomarker for disulfide bond enrichment and disease.

OTUD3: Structure and Function

OTUD3 is a 26 kDa protein that is expressed in various tissues and cells, including muscle, liver, and brain. OTUD3 is composed of a 252 amino acid protein that contains a unique disulfide bond, which is formed by the oxidation of a lysine residue to its amino acid side chain. The disulfide bond is located at the N-terminus of the protein and consists of a maleimyl group (3) that is covalently bound to the carbonyl group (4) of a lysine residue.

The function of OTUD3 is not well understood, but its involvement in disulfide bond formation is known. OTUD3 has been shown to play a role in the regulation of protein stability and to control the formation of disulfide bonds in various cellular processes. For example, studies have shown thatOTUD3 can enhance the stability of the protein p21 (7), a key regulator of the T-cell divide, by promoting the formation of a disulfide bond between the amino acids Asp21 and Asn22. Additionally, OTUD3 has been shown to play a role in the regulation of the stability of the protein parkin (9), a protein that is involved in the formation of mitochondrial organelles.

Drug Target Potential

The potential drug target for OTUD3 is the regulation of disulfide bond formation. Disulfide bond formation is a critical post-translational modification that is involved in the formation of numerous cellular structures, including proteins, DNA, and RNA. Therefore, inhibiting disulfide bond formation could lead to a therapeutic approach for a variety of diseases.

OTUD3 has been shown to be involved in the regulation of disulfide bond formation in various cellular processes. For example, studies have shown that OTUD3 can enhance the stability of the protein p21 by promoting the formation of a disulfide bond between the amino acids Asp21 and Asn22. Additionally, the disulfide bond formation activity of OTUD3 has been shown to play a role in the regulation of the stability of the protein parkin.

Biomarker Potential

The potential use of OTUD3 as a biomarker for disease has been identified due to its involvement in the regulation of disulfide bond formation. Disulfide bond formation is a critical post-translational modification that is involved in the formation of numerous cellular structures, including proteins, DNA, and RNA. Therefore, changes in disulfide bond formation have been implicated in the development and progression of a variety of diseases.

Studies have shown that OTUD3 has been expressed in various tissues and cells, including muscle, liver, and brain (1), and that it is involved in the regulation of disulfide bond formation in these cellular processes. Additionally, the disulfide bond formation activity of OTUD3 has been shown to play a role in the regulation of the stability of various cellular structures, including proteins (8), DNA (10), and RNA.

Conclusion

In conclusion, OTUD3 is a protein that has been identified as a potential drug target and biomarker for disulfide bond enrichment and disease. Its involvement in the regulation of disulfide bond formation in various cellular processes makes it a promising target for new therapies.

Protein Name: OTU Deubiquitinase 3

Functions: Deubiquitinating enzyme that hydrolyzes 'Lys-6'- and 'Lys-11'-linked polyubiquitin. Also hydrolyzes heterotypic (mixed and branched) and homotypic chains (PubMed:23827681, PubMed:35675826). Important regulator of energy metabolism. Glucose and fatty acids trigger its nuclear translocation by CBP-dependent acetylation. In the nucleus, deubiquitinates and stabilizes the nuclear receptor PPARD regulating the expression of various genes involved in glucose and lipid metabolism and oxidative phosphorylation (PubMed:35675826)

The "OTUD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTUD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets